If you need a reminder we are still alive in the midst of a global pandemic, here’s a courtesy of CVS. Friday, the chain of pharmacies said Business Insider than the company’s supply COVID takeaway tests are in high demand who will you have to start limiting the number that clients you can buy at the same time.
Until now, people could buy as many proofs as they wanted from the retailer, no questions asked. But as of Friday, customers can only buy six online at once or four at a time while shopping at the store. Gizmodo was able to confirm this while purchasing any local test on the CVS website, the maximum number you can add your cart is six.
CVS has not yet responded to Gizmodo’s request for comment, but the company cited the “high demand” for the tests as the reasons why customers were cut. And that demand makes sense, whether you consider it or not companies and schools trying to keep their own COVID numbers under control right now, and the way the pandemic is wreaking havoc in some states. This week, Alabama reported more than 5,500 new cases of coronavirus among school-age children, while dozens of unvaccinated adults across the state they have been dying en masse from the disease.
Florida, meanwhile, reports roughly 22,500 new cases which is added to their ranks daily and more than 200 dead. Arkansas reports The ICUs are packed to the capacity of the citizens who enter with cases of the Delta variant, as is Louisiana. Naturally, people in these areas will be on high alert and as a result can buy more evidence.
Apart from the increase in demand, some of these shortcomings go back to problems related to the supply chain of manufacturing companies. these home tests, such as the Abbott and Ellume diagnostic suits. Bloomberg reported that customers who try to collect each of the evidence from these companies, which are available without a prescription of CVS: they will face limits on the number of units they are allowed to take home.
G / O Media may receive a commission
An Abbott spokesman he told the Wall Street Journal which expects home testing supplies to be somewhat limited over the next few weeks as it works to hire more workers and restart factory lines that slowed earlier this summer. An Elume spokesman hinted that the company was facing similar problems and told Bloomberg it was busy “scaling production” to meet an unprecedented demand for its tests.